Comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors, sorafenib, lenvatinib, regorafenib and cabozantinib:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | English |
| Veröffentlicht: |
München
2023
|
| Schlagworte: | |
| Online-Zugang: | Volltext Volltext |
| Beschreibung: | 72 Seiten Illustrationen, Diagramme |
| DOI: | 10.5282/edoc.32420 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV049334616 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 230920s2023 gw a||| m||| 00||| eng d | ||
| 015 | |a 23,O10 |2 dnb | ||
| 035 | |a (OCoLC)1401202402 | ||
| 035 | |a (DE-599)BVBBV049334616 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-384 |a DE-473 |a DE-703 |a DE-1051 |a DE-824 |a DE-29 |a DE-12 |a DE-91 |a DE-19 |a DE-1049 |a DE-92 |a DE-739 |a DE-898 |a DE-355 |a DE-706 |a DE-20 |a DE-1102 |a DE-860 |a DE-2174 | ||
| 084 | |8 2\p |a 610 |2 23sdnb | ||
| 084 | |8 1\p |a 616.994 |2 23ksdnb | ||
| 100 | 1 | |a Sagmeister, Paula |e Verfasser |0 (DE-588)1302796569 |4 aut | |
| 245 | 1 | 0 | |a Comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors, sorafenib, lenvatinib, regorafenib and cabozantinib |c Paula Sagmeister |
| 264 | 1 | |a München |c 2023 | |
| 300 | |a 72 Seiten |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 502 | |b Dissertation |c München, Ludwig-Maximilians-Universität |d 2023 | ||
| 650 | 0 | 7 | |8 3\p |a Leberkrebs |0 (DE-588)4034943-3 |2 gnd |
| 650 | 0 | 7 | |8 4\p |a Therapie |0 (DE-588)4059798-2 |2 gnd |
| 650 | 0 | 7 | |8 5\p |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 776 | 1 | 8 | |i Erscheint auch als |n Online-Ausgabe |o urn:nbn:de:bvb:19-324209 |o 10.5282/edoc.32420 |
| 856 | 4 | 1 | |u https://doi.org/10.5282/edoc.32420 |x Verlag |z kostenfrei |3 Volltext |
| 856 | 4 | 1 | |u https://nbn-resolving.org/urn:nbn:de:bvb:19-324209 |x Resolving-System |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034595311 | ||
| 883 | 0 | |8 1\p |a emakn |c 0,95017 |d 20230919 |q DE-101 |u https://d-nb.info/provenance/plan#emakn | |
| 883 | 0 | |8 2\p |a emasg |c 0,96105 |d 20230919 |q DE-101 |u https://d-nb.info/provenance/plan#emasg | |
| 883 | 0 | |8 3\p |a emagnd |c 0,08762 |d 20230919 |q DE-101 |u https://d-nb.info/provenance/plan#emagnd | |
| 883 | 0 | |8 4\p |a emagnd |c 0,08592 |d 20230919 |q DE-101 |u https://d-nb.info/provenance/plan#emagnd | |
| 883 | 0 | |8 5\p |a emagnd |c 0,05888 |d 20230919 |q DE-101 |u https://d-nb.info/provenance/plan#emagnd | |
Datensatz im Suchindex
| _version_ | 1804185852891365376 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Sagmeister, Paula |
| author_GND | (DE-588)1302796569 |
| author_facet | Sagmeister, Paula |
| author_role | aut |
| author_sort | Sagmeister, Paula |
| author_variant | p s ps |
| building | Verbundindex |
| bvnumber | BV049334616 |
| collection | ebook |
| ctrlnum | (OCoLC)1401202402 (DE-599)BVBBV049334616 |
| doi_str_mv | 10.5282/edoc.32420 |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02151nam a2200457zc 4500</leader><controlfield tag="001">BV049334616</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">230920s2023 gw a||| m||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">23,O10</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1401202402</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049334616</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-384</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-1051</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-1102</subfield><subfield code="a">DE-860</subfield><subfield code="a">DE-2174</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">616.994</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sagmeister, Paula</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1302796569</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors, sorafenib, lenvatinib, regorafenib and cabozantinib</subfield><subfield code="c">Paula Sagmeister</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">München</subfield><subfield code="c">2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">72 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">München, Ludwig-Maximilians-Universität</subfield><subfield code="d">2023</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">3\p</subfield><subfield code="a">Leberkrebs</subfield><subfield code="0">(DE-588)4034943-3</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">4\p</subfield><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">5\p</subfield><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="776" ind1="1" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="o">urn:nbn:de:bvb:19-324209</subfield><subfield code="o">10.5282/edoc.32420</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">https://doi.org/10.5282/edoc.32420</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:19-324209</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034595311</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">emakn</subfield><subfield code="c">0,95017</subfield><subfield code="d">20230919</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emakn</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">emasg</subfield><subfield code="c">0,96105</subfield><subfield code="d">20230919</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emasg</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">emagnd</subfield><subfield code="c">0,08762</subfield><subfield code="d">20230919</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emagnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">emagnd</subfield><subfield code="c">0,08592</subfield><subfield code="d">20230919</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emagnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">5\p</subfield><subfield code="a">emagnd</subfield><subfield code="c">0,05888</subfield><subfield code="d">20230919</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emagnd</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV049334616 |
| illustrated | Illustrated |
| index_date | 2024-07-03T22:45:56Z |
| indexdate | 2024-07-10T10:01:49Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034595311 |
| oclc_num | 1401202402 |
| open_access_boolean | 1 |
| owner | DE-384 DE-473 DE-BY-UBG DE-703 DE-1051 DE-824 DE-29 DE-12 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-1049 DE-92 DE-739 DE-898 DE-BY-UBR DE-355 DE-BY-UBR DE-706 DE-20 DE-1102 DE-860 DE-2174 |
| owner_facet | DE-384 DE-473 DE-BY-UBG DE-703 DE-1051 DE-824 DE-29 DE-12 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-1049 DE-92 DE-739 DE-898 DE-BY-UBR DE-355 DE-BY-UBR DE-706 DE-20 DE-1102 DE-860 DE-2174 |
| physical | 72 Seiten Illustrationen, Diagramme |
| psigel | ebook |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| record_format | marc |
| spelling | Sagmeister, Paula Verfasser (DE-588)1302796569 aut Comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors, sorafenib, lenvatinib, regorafenib and cabozantinib Paula Sagmeister München 2023 72 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier Dissertation München, Ludwig-Maximilians-Universität 2023 3\p Leberkrebs (DE-588)4034943-3 gnd 4\p Therapie (DE-588)4059798-2 gnd 5\p Cytostatikum (DE-588)4068347-3 gnd (DE-588)4113937-9 Hochschulschrift gnd-content Erscheint auch als Online-Ausgabe urn:nbn:de:bvb:19-324209 10.5282/edoc.32420 https://doi.org/10.5282/edoc.32420 Verlag kostenfrei Volltext https://nbn-resolving.org/urn:nbn:de:bvb:19-324209 Resolving-System kostenfrei Volltext 1\p emakn 0,95017 20230919 DE-101 https://d-nb.info/provenance/plan#emakn 2\p emasg 0,96105 20230919 DE-101 https://d-nb.info/provenance/plan#emasg 3\p emagnd 0,08762 20230919 DE-101 https://d-nb.info/provenance/plan#emagnd 4\p emagnd 0,08592 20230919 DE-101 https://d-nb.info/provenance/plan#emagnd 5\p emagnd 0,05888 20230919 DE-101 https://d-nb.info/provenance/plan#emagnd |
| spellingShingle | Sagmeister, Paula Comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors, sorafenib, lenvatinib, regorafenib and cabozantinib 3\p Leberkrebs (DE-588)4034943-3 gnd 4\p Therapie (DE-588)4059798-2 gnd 5\p Cytostatikum (DE-588)4068347-3 gnd |
| subject_GND | (DE-588)4034943-3 (DE-588)4059798-2 (DE-588)4068347-3 (DE-588)4113937-9 |
| title | Comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors, sorafenib, lenvatinib, regorafenib and cabozantinib |
| title_auth | Comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors, sorafenib, lenvatinib, regorafenib and cabozantinib |
| title_exact_search | Comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors, sorafenib, lenvatinib, regorafenib and cabozantinib |
| title_exact_search_txtP | Comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors, sorafenib, lenvatinib, regorafenib and cabozantinib |
| title_full | Comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors, sorafenib, lenvatinib, regorafenib and cabozantinib Paula Sagmeister |
| title_fullStr | Comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors, sorafenib, lenvatinib, regorafenib and cabozantinib Paula Sagmeister |
| title_full_unstemmed | Comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors, sorafenib, lenvatinib, regorafenib and cabozantinib Paula Sagmeister |
| title_short | Comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors, sorafenib, lenvatinib, regorafenib and cabozantinib |
| title_sort | comparative response of nine hepatoma cell lines to the four tyrosine kinase inhibitors sorafenib lenvatinib regorafenib and cabozantinib |
| topic | 3\p Leberkrebs (DE-588)4034943-3 gnd 4\p Therapie (DE-588)4059798-2 gnd 5\p Cytostatikum (DE-588)4068347-3 gnd |
| topic_facet | Leberkrebs Therapie Cytostatikum Hochschulschrift |
| url | https://doi.org/10.5282/edoc.32420 https://nbn-resolving.org/urn:nbn:de:bvb:19-324209 |
| work_keys_str_mv | AT sagmeisterpaula comparativeresponseofninehepatomacelllinestothefourtyrosinekinaseinhibitorssorafeniblenvatinibregorafenibandcabozantinib |